GFAP and central nervous system cancer: Not GFAP, but GFAP autoantibodies were very recently demonstrated to be a useful serum marker for glioma patients [3], possibly due to the fact that blood brain barrier (otherwise impermeable for antibodies) is altered in advanced or aggressive disease.